Columbus, OH (PRWEB) November 13, 2013
As The Courts Continue To Receive Pradaxa Lawsuits, Wright & Schulte LLC Files A Pradaxa Internal Bleeding Lawsuit Aleging A Woman’s Wrongful Death Was From a Gastrointestinal Hemorrhage Due To Pradaxa
Pradaxa internal bleeding lawsuits alleging serious injury and wrongful death due to Pradaxa bleeding side effects continue to mount in courts around the country, Wright & Schulte LLC reports. According to court documents filed in U.S. District Court, Eastern District of Pennsylvania, the most recent Pradaxa internal bleeding wrongful death claim was filed by two daughters who allege that a fatal gastrointestinal hemorrhage suffered by their mother was the result of Pradaxa. (Case No. 2:13-cv-06488-GP)
According to the Pradaxa lawsuit, the Plaintiffs’ mother began taking the blood thinner in early 2012 to treat non-valvular atrial fibrillation, a disorder associated with an increased risk of stroke. Four months after the drug was first prescribed, the woman to suffer a gastrointestinal hemorrhage and subsequently died after being taken to the Hospital of the University of Pennsylvania. The complaint asserts that the “excessive and/or uncontrollable bleeding” suffered by the woman and which resulted in her death “was caused and/or worsened by Plaintiff’s use of Pradaxa.”
The complaint further alleges that Boehringer Ingelheim Pharmaceuticals, the manufacturer of the drug, over-promoted Pradaxa, and knew or should have known that Pradaxa’s original labeling did not adequately disclose its risks, including the fact that there is no reversal agent currently available to stop Pradaxa bleeding. Finally, the Pradaxa lawsuit alleges that du
Copyright©2012 Vocus, Inc.
All rights reserved